JEP 533, Structured Concurrency, has reached integrated status for JDK 27. It refines exception handling and type safety in ...
WASHINGTON, April 29 (Reuters) - The U.S. Supreme Court on Wednesday heard a patent dispute over a generic version of Amarin Pharma's (AMRN.O), opens new tab cardiovascular drug Vascepa that could ...
“We all know Michael Jackson, but the human is in Michael,” Antoine Fuqua said, explaining the intentional choice behind the biopic’s title. When you hear the name Michael Jackson, there are a ...
The 16-team NBA postseason bracket will be completed over the next four days through the play-in tournament. Four teams in each conference face off against each other to fill in the No. 7 and No. 8 ...
Six weeks after the beginning of the war with Iran, President Donald Trump is giving the United States Navy its most difficult jobs of the conflict: blockading Iran’s ports and clearing the strategic ...
John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Lizzy Lawrence leads STAT’s ...
Generic dapagliflozin is indicated to lower heart failure hospitalization risk in type 2 diabetes with established cardiovascular disease or multiple risk factors, and to improve glycemic control ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Steve Jobs with room full of computers, 1984. (Photo by Michael L Abramson/Getty Images) ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Ozempic and Wegovy are injectable prescription weight-loss medicines made by Danish ...
India is launching cheap weight-loss drugs — but Novo Nordisk is betting its brands will stay on top
Novo lost semaglutide patent protection in India, triggering generic launches. Indian drugmakers launched generic versions at lower prices. Novo cut prices and used partnerships to defend market share ...
With patents expiring today in India for Novo Nordisk’s popular diabetes and obesity drugs Ozempic and Wegovy, more than 40 generic drug makers are expected to begin launching their cheaper versions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results